nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2A—myenteric nerve plexus—colon cancer	0.0128	0.17	CbGeAlD
Pramipexole—HTR2A—vein—colon cancer	0.00822	0.109	CbGeAlD
Pramipexole—HTR1B—blood vessel—colon cancer	0.00542	0.0722	CbGeAlD
Pramipexole—HTR1D—blood vessel—colon cancer	0.00525	0.0699	CbGeAlD
Pramipexole—SLC22A2—renal system—colon cancer	0.00339	0.0451	CbGeAlD
Pramipexole—DRD5—lymphoid tissue—colon cancer	0.00328	0.0437	CbGeAlD
Pramipexole—HTR2A—endothelium—colon cancer	0.00283	0.0377	CbGeAlD
Pramipexole—SLC22A2—digestive system—colon cancer	0.00278	0.037	CbGeAlD
Pramipexole—HTR2A—blood vessel—colon cancer	0.00261	0.0347	CbGeAlD
Pramipexole—SLC22A1—renal system—colon cancer	0.00239	0.0319	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—colon cancer	0.00229	0.0305	CbGeAlD
Pramipexole—HTR1A—renal system—colon cancer	0.00198	0.0263	CbGeAlD
Pramipexole—HTR2B—digestive system—colon cancer	0.00181	0.0241	CbGeAlD
Pramipexole—ADRA2C—renal system—colon cancer	0.00174	0.0231	CbGeAlD
Pramipexole—SLC22A1—vagina—colon cancer	0.00173	0.0231	CbGeAlD
Pramipexole—HTR2B—vagina—colon cancer	0.0016	0.0213	CbGeAlD
Pramipexole—HTR2A—embryo—colon cancer	0.00156	0.0207	CbGeAlD
Pramipexole—SLC22A1—liver—colon cancer	0.00146	0.0195	CbGeAlD
Pramipexole—HTR2A—epithelium—colon cancer	0.00127	0.0169	CbGeAlD
Pramipexole—ADRA2C—vagina—colon cancer	0.00126	0.0167	CbGeAlD
Pramipexole—HTR2A—smooth muscle tissue—colon cancer	0.00122	0.0163	CbGeAlD
Pramipexole—HTR2A—renal system—colon cancer	0.00118	0.0157	CbGeAlD
Pramipexole—ADRA2C—liver—colon cancer	0.00106	0.0141	CbGeAlD
Pramipexole—HTR2B—lymph node—colon cancer	0.00103	0.0138	CbGeAlD
Pramipexole—ADRA2A—vagina—colon cancer	0.001	0.0134	CbGeAlD
Pramipexole—HTR2A—digestive system—colon cancer	0.000966	0.0129	CbGeAlD
Pramipexole—HTR2A—vagina—colon cancer	0.000853	0.0114	CbGeAlD
Pramipexole—ADRA2C—lymph node—colon cancer	0.000813	0.0108	CbGeAlD
Pramipexole—HTR2A—liver—colon cancer	0.000719	0.00958	CbGeAlD
Pramipexole—Infection—Irinotecan—colon cancer	0.000674	0.000729	CcSEcCtD
Pramipexole—Hyperhidrosis—Vincristine—colon cancer	0.000674	0.000728	CcSEcCtD
Pramipexole—Hepatobiliary disease—Capecitabine—colon cancer	0.000673	0.000728	CcSEcCtD
Pramipexole—Epistaxis—Capecitabine—colon cancer	0.000672	0.000726	CcSEcCtD
Pramipexole—Discomfort—Fluorouracil—colon cancer	0.00067	0.000724	CcSEcCtD
Pramipexole—Shock—Irinotecan—colon cancer	0.000668	0.000722	CcSEcCtD
Pramipexole—Nervous system disorder—Irinotecan—colon cancer	0.000665	0.00072	CcSEcCtD
Pramipexole—Thrombocytopenia—Irinotecan—colon cancer	0.000664	0.000718	CcSEcCtD
Pramipexole—Anorexia—Vincristine—colon cancer	0.000664	0.000718	CcSEcCtD
Pramipexole—Irritability—Methotrexate—colon cancer	0.000657	0.00071	CcSEcCtD
Pramipexole—Hyperhidrosis—Irinotecan—colon cancer	0.000656	0.000709	CcSEcCtD
Pramipexole—Confusional state—Fluorouracil—colon cancer	0.000655	0.000709	CcSEcCtD
Pramipexole—Mood swings—Methotrexate—colon cancer	0.000652	0.000705	CcSEcCtD
Pramipexole—Hypotension—Vincristine—colon cancer	0.000651	0.000704	CcSEcCtD
Pramipexole—Bradycardia—Capecitabine—colon cancer	0.000651	0.000704	CcSEcCtD
Pramipexole—Oedema—Fluorouracil—colon cancer	0.00065	0.000703	CcSEcCtD
Pramipexole—ADRA2A—lymph node—colon cancer	0.000649	0.00864	CbGeAlD
Pramipexole—Anorexia—Irinotecan—colon cancer	0.000647	0.000699	CcSEcCtD
Pramipexole—Ataxia—Methotrexate—colon cancer	0.000647	0.000699	CcSEcCtD
Pramipexole—Infection—Fluorouracil—colon cancer	0.000646	0.000698	CcSEcCtD
Pramipexole—Rhinitis—Capecitabine—colon cancer	0.000641	0.000693	CcSEcCtD
Pramipexole—Nervous system disorder—Fluorouracil—colon cancer	0.000637	0.000689	CcSEcCtD
Pramipexole—Thrombocytopenia—Fluorouracil—colon cancer	0.000636	0.000688	CcSEcCtD
Pramipexole—Hypoaesthesia—Capecitabine—colon cancer	0.000636	0.000688	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000635	0.000686	CcSEcCtD
Pramipexole—Pharyngitis—Capecitabine—colon cancer	0.000634	0.000686	CcSEcCtD
Pramipexole—Tachycardia—Fluorouracil—colon cancer	0.000634	0.000686	CcSEcCtD
Pramipexole—Hypotension—Irinotecan—colon cancer	0.000634	0.000686	CcSEcCtD
Pramipexole—Urinary tract disorder—Capecitabine—colon cancer	0.000631	0.000683	CcSEcCtD
Pramipexole—Insomnia—Vincristine—colon cancer	0.00063	0.000681	CcSEcCtD
Pramipexole—Oedema peripheral—Capecitabine—colon cancer	0.00063	0.000681	CcSEcCtD
Pramipexole—Connective tissue disorder—Capecitabine—colon cancer	0.000628	0.000679	CcSEcCtD
Pramipexole—Urethral disorder—Capecitabine—colon cancer	0.000627	0.000678	CcSEcCtD
Pramipexole—Paraesthesia—Vincristine—colon cancer	0.000626	0.000676	CcSEcCtD
Pramipexole—Breast disorder—Methotrexate—colon cancer	0.000622	0.000672	CcSEcCtD
Pramipexole—Anorexia—Fluorouracil—colon cancer	0.00062	0.00067	CcSEcCtD
Pramipexole—Visual impairment—Capecitabine—colon cancer	0.000616	0.000666	CcSEcCtD
Pramipexole—Insomnia—Irinotecan—colon cancer	0.000614	0.000664	CcSEcCtD
Pramipexole—Paraesthesia—Irinotecan—colon cancer	0.000609	0.000659	CcSEcCtD
Pramipexole—Hypotension—Fluorouracil—colon cancer	0.000607	0.000657	CcSEcCtD
Pramipexole—Decreased appetite—Vincristine—colon cancer	0.000606	0.000655	CcSEcCtD
Pramipexole—Dyspnoea—Irinotecan—colon cancer	0.000605	0.000654	CcSEcCtD
Pramipexole—Somnolence—Irinotecan—colon cancer	0.000603	0.000652	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Vincristine—colon cancer	0.000602	0.00065	CcSEcCtD
Pramipexole—Fatigue—Vincristine—colon cancer	0.000601	0.00065	CcSEcCtD
Pramipexole—Eye disorder—Capecitabine—colon cancer	0.000597	0.000646	CcSEcCtD
Pramipexole—Dyspepsia—Irinotecan—colon cancer	0.000597	0.000646	CcSEcCtD
Pramipexole—Tinnitus—Capecitabine—colon cancer	0.000596	0.000644	CcSEcCtD
Pramipexole—Pain—Vincristine—colon cancer	0.000596	0.000644	CcSEcCtD
Pramipexole—Constipation—Vincristine—colon cancer	0.000596	0.000644	CcSEcCtD
Pramipexole—Asthma—Methotrexate—colon cancer	0.000595	0.000643	CcSEcCtD
Pramipexole—Cardiac disorder—Capecitabine—colon cancer	0.000593	0.000641	CcSEcCtD
Pramipexole—Flushing—Capecitabine—colon cancer	0.000593	0.000641	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000592	0.00064	CcSEcCtD
Pramipexole—Decreased appetite—Irinotecan—colon cancer	0.00059	0.000638	CcSEcCtD
Pramipexole—Insomnia—Fluorouracil—colon cancer	0.000588	0.000636	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000586	0.000633	CcSEcCtD
Pramipexole—Fatigue—Irinotecan—colon cancer	0.000585	0.000633	CcSEcCtD
Pramipexole—Paraesthesia—Fluorouracil—colon cancer	0.000584	0.000631	CcSEcCtD
Pramipexole—Pancreatitis—Methotrexate—colon cancer	0.000583	0.00063	CcSEcCtD
Pramipexole—Pain—Irinotecan—colon cancer	0.00058	0.000627	CcSEcCtD
Pramipexole—Constipation—Irinotecan—colon cancer	0.00058	0.000627	CcSEcCtD
Pramipexole—Angiopathy—Capecitabine—colon cancer	0.00058	0.000627	CcSEcCtD
Pramipexole—Dyspnoea—Fluorouracil—colon cancer	0.000579	0.000626	CcSEcCtD
Pramipexole—Somnolence—Fluorouracil—colon cancer	0.000578	0.000625	CcSEcCtD
Pramipexole—Immune system disorder—Capecitabine—colon cancer	0.000577	0.000624	CcSEcCtD
Pramipexole—Mediastinal disorder—Capecitabine—colon cancer	0.000576	0.000623	CcSEcCtD
Pramipexole—Chills—Capecitabine—colon cancer	0.000574	0.00062	CcSEcCtD
Pramipexole—Dyspepsia—Fluorouracil—colon cancer	0.000572	0.000619	CcSEcCtD
Pramipexole—Abdominal discomfort—Methotrexate—colon cancer	0.00057	0.000616	CcSEcCtD
Pramipexole—Gastrointestinal pain—Vincristine—colon cancer	0.00057	0.000616	CcSEcCtD
Pramipexole—Decreased appetite—Fluorouracil—colon cancer	0.000565	0.000611	CcSEcCtD
Pramipexole—Alopecia—Capecitabine—colon cancer	0.000565	0.000611	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000561	0.000607	CcSEcCtD
Pramipexole—Mental disorder—Capecitabine—colon cancer	0.00056	0.000606	CcSEcCtD
Pramipexole—Feeling abnormal—Irinotecan—colon cancer	0.000559	0.000605	CcSEcCtD
Pramipexole—Malnutrition—Capecitabine—colon cancer	0.000556	0.000602	CcSEcCtD
Pramipexole—Erythema—Capecitabine—colon cancer	0.000556	0.000602	CcSEcCtD
Pramipexole—Dysuria—Methotrexate—colon cancer	0.000556	0.000601	CcSEcCtD
Pramipexole—Pain—Fluorouracil—colon cancer	0.000556	0.000601	CcSEcCtD
Pramipexole—Gastrointestinal pain—Irinotecan—colon cancer	0.000555	0.0006	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000553	0.000597	CcSEcCtD
Pramipexole—Abdominal pain—Vincristine—colon cancer	0.000551	0.000596	CcSEcCtD
Pramipexole—Body temperature increased—Vincristine—colon cancer	0.000551	0.000596	CcSEcCtD
Pramipexole—Flatulence—Capecitabine—colon cancer	0.000548	0.000593	CcSEcCtD
Pramipexole—Erectile dysfunction—Methotrexate—colon cancer	0.000548	0.000592	CcSEcCtD
Pramipexole—Dysgeusia—Capecitabine—colon cancer	0.000545	0.000589	CcSEcCtD
Pramipexole—Photosensitivity reaction—Methotrexate—colon cancer	0.000543	0.000587	CcSEcCtD
Pramipexole—Back pain—Capecitabine—colon cancer	0.000538	0.000582	CcSEcCtD
Pramipexole—Abdominal pain—Irinotecan—colon cancer	0.000536	0.00058	CcSEcCtD
Pramipexole—Body temperature increased—Irinotecan—colon cancer	0.000536	0.00058	CcSEcCtD
Pramipexole—Feeling abnormal—Fluorouracil—colon cancer	0.000536	0.000579	CcSEcCtD
Pramipexole—Muscle spasms—Capecitabine—colon cancer	0.000535	0.000578	CcSEcCtD
Pramipexole—Pneumonia—Methotrexate—colon cancer	0.000533	0.000576	CcSEcCtD
Pramipexole—Infestation NOS—Methotrexate—colon cancer	0.00053	0.000573	CcSEcCtD
Pramipexole—Drowsiness—Methotrexate—colon cancer	0.00053	0.000573	CcSEcCtD
Pramipexole—Infestation—Methotrexate—colon cancer	0.00053	0.000573	CcSEcCtD
Pramipexole—Depression—Methotrexate—colon cancer	0.000529	0.000571	CcSEcCtD
Pramipexole—Vision blurred—Capecitabine—colon cancer	0.000524	0.000567	CcSEcCtD
Pramipexole—Tremor—Capecitabine—colon cancer	0.000521	0.000564	CcSEcCtD
Pramipexole—Renal failure—Methotrexate—colon cancer	0.000521	0.000563	CcSEcCtD
Pramipexole—Ill-defined disorder—Capecitabine—colon cancer	0.000516	0.000558	CcSEcCtD
Pramipexole—Urticaria—Fluorouracil—colon cancer	0.000516	0.000558	CcSEcCtD
Pramipexole—Conjunctivitis—Methotrexate—colon cancer	0.000515	0.000557	CcSEcCtD
Pramipexole—Anaemia—Capecitabine—colon cancer	0.000514	0.000556	CcSEcCtD
Pramipexole—Body temperature increased—Fluorouracil—colon cancer	0.000514	0.000555	CcSEcCtD
Pramipexole—Hypersensitivity—Vincristine—colon cancer	0.000513	0.000555	CcSEcCtD
Pramipexole—Sweating—Methotrexate—colon cancer	0.000508	0.000549	CcSEcCtD
Pramipexole—Haematuria—Methotrexate—colon cancer	0.000505	0.000546	CcSEcCtD
Pramipexole—Malaise—Capecitabine—colon cancer	0.000502	0.000543	CcSEcCtD
Pramipexole—Hepatobiliary disease—Methotrexate—colon cancer	0.000501	0.000542	CcSEcCtD
Pramipexole—Epistaxis—Methotrexate—colon cancer	0.0005	0.000541	CcSEcCtD
Pramipexole—Vertigo—Capecitabine—colon cancer	0.0005	0.000541	CcSEcCtD
Pramipexole—Hypersensitivity—Irinotecan—colon cancer	0.0005	0.000541	CcSEcCtD
Pramipexole—Asthenia—Vincristine—colon cancer	0.0005	0.000541	CcSEcCtD
Pramipexole—Syncope—Capecitabine—colon cancer	0.000499	0.00054	CcSEcCtD
Pramipexole—Leukopenia—Capecitabine—colon cancer	0.000498	0.000539	CcSEcCtD
Pramipexole—Palpitations—Capecitabine—colon cancer	0.000492	0.000532	CcSEcCtD
Pramipexole—Loss of consciousness—Capecitabine—colon cancer	0.000489	0.000529	CcSEcCtD
Pramipexole—Asthenia—Irinotecan—colon cancer	0.000487	0.000526	CcSEcCtD
Pramipexole—Cough—Capecitabine—colon cancer	0.000486	0.000525	CcSEcCtD
Pramipexole—Hypertension—Capecitabine—colon cancer	0.00048	0.000519	CcSEcCtD
Pramipexole—Hypersensitivity—Fluorouracil—colon cancer	0.000479	0.000518	CcSEcCtD
Pramipexole—Diarrhoea—Vincristine—colon cancer	0.000477	0.000515	CcSEcCtD
Pramipexole—Myalgia—Capecitabine—colon cancer	0.000474	0.000512	CcSEcCtD
Pramipexole—Chest pain—Capecitabine—colon cancer	0.000474	0.000512	CcSEcCtD
Pramipexole—Arthralgia—Capecitabine—colon cancer	0.000474	0.000512	CcSEcCtD
Pramipexole—Pharyngitis—Methotrexate—colon cancer	0.000472	0.000511	CcSEcCtD
Pramipexole—Anxiety—Capecitabine—colon cancer	0.000472	0.00051	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000471	0.000509	CcSEcCtD
Pramipexole—Urinary tract disorder—Methotrexate—colon cancer	0.00047	0.000508	CcSEcCtD
Pramipexole—Discomfort—Capecitabine—colon cancer	0.000468	0.000506	CcSEcCtD
Pramipexole—Urethral disorder—Methotrexate—colon cancer	0.000466	0.000504	CcSEcCtD
Pramipexole—Diarrhoea—Irinotecan—colon cancer	0.000464	0.000502	CcSEcCtD
Pramipexole—Dry mouth—Capecitabine—colon cancer	0.000463	0.000501	CcSEcCtD
Pramipexole—Dizziness—Vincristine—colon cancer	0.000461	0.000498	CcSEcCtD
Pramipexole—Pruritus—Fluorouracil—colon cancer	0.00046	0.000497	CcSEcCtD
Pramipexole—Visual impairment—Methotrexate—colon cancer	0.000459	0.000496	CcSEcCtD
Pramipexole—Confusional state—Capecitabine—colon cancer	0.000458	0.000495	CcSEcCtD
Pramipexole—Oedema—Capecitabine—colon cancer	0.000454	0.000491	CcSEcCtD
Pramipexole—Infection—Capecitabine—colon cancer	0.000451	0.000488	CcSEcCtD
Pramipexole—Dizziness—Irinotecan—colon cancer	0.000449	0.000485	CcSEcCtD
Pramipexole—Shock—Capecitabine—colon cancer	0.000447	0.000483	CcSEcCtD
Pramipexole—Nervous system disorder—Capecitabine—colon cancer	0.000445	0.000482	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—colon cancer	0.000445	0.000481	CcSEcCtD
Pramipexole—Diarrhoea—Fluorouracil—colon cancer	0.000445	0.000481	CcSEcCtD
Pramipexole—Thrombocytopenia—Capecitabine—colon cancer	0.000445	0.000481	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—colon cancer	0.000444	0.00048	CcSEcCtD
Pramipexole—Tachycardia—Capecitabine—colon cancer	0.000443	0.000479	CcSEcCtD
Pramipexole—Vomiting—Vincristine—colon cancer	0.000443	0.000479	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—colon cancer	0.000442	0.000478	CcSEcCtD
Pramipexole—Skin disorder—Capecitabine—colon cancer	0.000441	0.000477	CcSEcCtD
Pramipexole—Rash—Vincristine—colon cancer	0.000439	0.000475	CcSEcCtD
Pramipexole—Hyperhidrosis—Capecitabine—colon cancer	0.000439	0.000475	CcSEcCtD
Pramipexole—Dermatitis—Vincristine—colon cancer	0.000439	0.000475	CcSEcCtD
Pramipexole—Headache—Vincristine—colon cancer	0.000437	0.000472	CcSEcCtD
Pramipexole—Anorexia—Capecitabine—colon cancer	0.000433	0.000468	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—colon cancer	0.000432	0.000467	CcSEcCtD
Pramipexole—Vomiting—Irinotecan—colon cancer	0.000431	0.000466	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—colon cancer	0.00043	0.000465	CcSEcCtD
Pramipexole—Dizziness—Fluorouracil—colon cancer	0.00043	0.000465	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—colon cancer	0.000429	0.000464	CcSEcCtD
Pramipexole—Rash—Irinotecan—colon cancer	0.000428	0.000463	CcSEcCtD
Pramipexole—Dermatitis—Irinotecan—colon cancer	0.000427	0.000462	CcSEcCtD
Pramipexole—Chills—Methotrexate—colon cancer	0.000427	0.000462	CcSEcCtD
Pramipexole—Headache—Irinotecan—colon cancer	0.000425	0.00046	CcSEcCtD
Pramipexole—Hypotension—Capecitabine—colon cancer	0.000424	0.000459	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—colon cancer	0.000421	0.000455	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—colon cancer	0.000417	0.000451	CcSEcCtD
Pramipexole—Erythema—Methotrexate—colon cancer	0.000414	0.000448	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—colon cancer	0.000414	0.000448	CcSEcCtD
Pramipexole—Nausea—Vincristine—colon cancer	0.000414	0.000447	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000414	0.000447	CcSEcCtD
Pramipexole—Vomiting—Fluorouracil—colon cancer	0.000413	0.000447	CcSEcCtD
Pramipexole—Insomnia—Capecitabine—colon cancer	0.000411	0.000444	CcSEcCtD
Pramipexole—Rash—Fluorouracil—colon cancer	0.00041	0.000443	CcSEcCtD
Pramipexole—Dermatitis—Fluorouracil—colon cancer	0.000409	0.000443	CcSEcCtD
Pramipexole—Paraesthesia—Capecitabine—colon cancer	0.000408	0.000441	CcSEcCtD
Pramipexole—Headache—Fluorouracil—colon cancer	0.000407	0.00044	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—colon cancer	0.000406	0.000439	CcSEcCtD
Pramipexole—Dyspnoea—Capecitabine—colon cancer	0.000405	0.000438	CcSEcCtD
Pramipexole—Nausea—Irinotecan—colon cancer	0.000403	0.000436	CcSEcCtD
Pramipexole—Back pain—Methotrexate—colon cancer	0.000401	0.000433	CcSEcCtD
Pramipexole—Dyspepsia—Capecitabine—colon cancer	0.0004	0.000432	CcSEcCtD
Pramipexole—Decreased appetite—Capecitabine—colon cancer	0.000395	0.000427	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000392	0.000424	CcSEcCtD
Pramipexole—Fatigue—Capecitabine—colon cancer	0.000392	0.000423	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—colon cancer	0.00039	0.000422	CcSEcCtD
Pramipexole—Pain—Capecitabine—colon cancer	0.000388	0.00042	CcSEcCtD
Pramipexole—Constipation—Capecitabine—colon cancer	0.000388	0.00042	CcSEcCtD
Pramipexole—Nausea—Fluorouracil—colon cancer	0.000386	0.000417	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—colon cancer	0.000384	0.000416	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—colon cancer	0.000383	0.000414	CcSEcCtD
Pramipexole—Feeling abnormal—Capecitabine—colon cancer	0.000374	0.000405	CcSEcCtD
Pramipexole—Malaise—Methotrexate—colon cancer	0.000374	0.000404	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—colon cancer	0.000372	0.000402	CcSEcCtD
Pramipexole—Gastrointestinal pain—Capecitabine—colon cancer	0.000371	0.000402	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—colon cancer	0.000371	0.000401	CcSEcCtD
Pramipexole—Cough—Methotrexate—colon cancer	0.000361	0.000391	CcSEcCtD
Pramipexole—Urticaria—Capecitabine—colon cancer	0.000361	0.00039	CcSEcCtD
Pramipexole—Body temperature increased—Capecitabine—colon cancer	0.000359	0.000388	CcSEcCtD
Pramipexole—Abdominal pain—Capecitabine—colon cancer	0.000359	0.000388	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—colon cancer	0.000359	0.000388	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—colon cancer	0.000353	0.000381	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—colon cancer	0.000353	0.000381	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—colon cancer	0.000353	0.000381	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00035	0.000379	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—colon cancer	0.000348	0.000377	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—colon cancer	0.000341	0.000369	CcSEcCtD
Pramipexole—Infection—Methotrexate—colon cancer	0.000336	0.000363	CcSEcCtD
Pramipexole—Hypersensitivity—Capecitabine—colon cancer	0.000335	0.000362	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—colon cancer	0.000332	0.000358	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—colon cancer	0.000331	0.000358	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—colon cancer	0.000328	0.000355	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—colon cancer	0.000327	0.000353	CcSEcCtD
Pramipexole—Asthenia—Capecitabine—colon cancer	0.000326	0.000352	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—colon cancer	0.000322	0.000348	CcSEcCtD
Pramipexole—Pruritus—Capecitabine—colon cancer	0.000321	0.000347	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—colon cancer	0.000316	0.000342	CcSEcCtD
Pramipexole—Diarrhoea—Capecitabine—colon cancer	0.000311	0.000336	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000308	0.000333	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—colon cancer	0.000306	0.000331	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—colon cancer	0.000304	0.000328	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—colon cancer	0.000301	0.000326	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—colon cancer	0.000301	0.000325	CcSEcCtD
Pramipexole—Dizziness—Capecitabine—colon cancer	0.0003	0.000325	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—colon cancer	0.000298	0.000322	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—colon cancer	0.000294	0.000318	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000292	0.000316	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—colon cancer	0.000291	0.000315	CcSEcCtD
Pramipexole—Pain—Methotrexate—colon cancer	0.000289	0.000313	CcSEcCtD
Pramipexole—Vomiting—Capecitabine—colon cancer	0.000289	0.000312	CcSEcCtD
Pramipexole—Rash—Capecitabine—colon cancer	0.000286	0.00031	CcSEcCtD
Pramipexole—Dermatitis—Capecitabine—colon cancer	0.000286	0.000309	CcSEcCtD
Pramipexole—Headache—Capecitabine—colon cancer	0.000285	0.000308	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—colon cancer	0.000279	0.000301	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—colon cancer	0.000276	0.000299	CcSEcCtD
Pramipexole—Nausea—Capecitabine—colon cancer	0.00027	0.000292	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—colon cancer	0.000269	0.00029	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—colon cancer	0.000267	0.000289	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—colon cancer	0.000267	0.000289	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—colon cancer	0.000249	0.000269	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—colon cancer	0.000243	0.000262	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—colon cancer	0.000239	0.000259	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—colon cancer	0.000231	0.00025	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—colon cancer	0.000224	0.000242	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—colon cancer	0.000215	0.000232	CcSEcCtD
Pramipexole—Rash—Methotrexate—colon cancer	0.000213	0.00023	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—colon cancer	0.000213	0.00023	CcSEcCtD
Pramipexole—Headache—Methotrexate—colon cancer	0.000212	0.000229	CcSEcCtD
Pramipexole—Nausea—Methotrexate—colon cancer	0.000201	0.000217	CcSEcCtD
